Biochemistry · 2016 · 67 citations · 14 references
PharmacyMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug DiscoveryNeuropharmacologyAmyloid FormationEnzyme InhibitionLead DiscoveryNatural Product Drug DiscoveryAmyloid Fibril FormationAmyloid FibrilsAmyloid InhibitionAmyloid StructureAmyloidogenic ProteinsInhibition Of Amyloid FormationLead Compound ScreeningTherapeutic Targeting Of Amyloid
Amyloid formation of the 37-residue amylin is involved in the pathogenesis of type 2 diabetes and, potentially, diabetes-induced neurological deficits. Numerous flavonoids exhibit inhibitory effects against amylin amyloidosis, but the mechanisms of inhibition remain unclear. Screening a library of natural compounds uncovered a potent lead compound, the flavone baicalein. Baicalein inhibits amylin amyloid formation and reduces amylin-induced cytotoxicity. Analogue analyses demonstrated, for the first time, key roles of the vicinal hydroxyl groups on the A-ring. We provided mass spectrometric evidence that incubating baicalein and amylin leads to their conjugation, consistent with a Schiff base mechanism.
14
Amylin deposition in the brain: A second amyloid in Alzheimer disease?
Kaleena Jackson, Gustavo A. Barisone, Lee‐Way Jin et al. · Annals of Neurology · 2013 · 336 citations · Full text
Medicine, Neurobiology, Neurology +17
Fanling Meng, Andisheh Abedini, Annette Plesner et al. · Biochemistry · 2010 · 279 citations